(Reuters) - Bristol-Myers Squibb Co said it would invest in Dutch biotech uniQure NV to get access to uniQure's gene therapy technology platform for cardiovascular diseases.
via Reuters: Health News Read More Here..
via Reuters: Health News Read More Here..
No comments:
Post a Comment